Electromed, Inc.
ELMD · Electromedical & Electrotherapeutic Apparatus · 8.3M shares · +0%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$1M (gross $275K, SBC $2M)
Reference price $36.25 · est. market cap ~$300M — last insider sale, 2026-06-08 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
B80Electromed — small but high-return airway-clearance (SmartVest) device maker.
Strengths
- ROE 17.4% (84th pct), ROA (97th), operating margin (85th)
- Strong gross margin (82nd), liquidity (current 4.3) and FCF (90th)
Risks
- Reimbursement and referral-channel dependence
- Small scale; single-product-family concentration
Notable findings
- Insider sellingInsider selling — 9 open-market sale(s) by 3 insider(s) (cluster of 3 insiders, ~$2M, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
78.1%
Operating margin
15.1%
Net margin
11.8%
Return on equity
17.4%
Return on assets
14.0%
Revenue growth (QoQ)
-1.7%
Net-income growth
46.3%
Current ratio
4.3×
Free cash flow
$11M
Tangible book value
$43M
Cash & investments
$15M
Stock comp / revenue
4.8%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-08 | Cunniff James L. | Sell | 1.7K | $36.80 |
| 2026-06-08 | Cunniff James L. | Sell | 1.0K | $37.77 |
| 2026-06-08 | Cunniff James L. | Option exercise | 9.7K | $17.25 |
| 2026-06-08 | Cunniff James L. | Sell | 7.0K | $36.25 |
| 2026-06-04 | Nagel Bradley M. | Option exercise | 4.3K | $10.25 |
| 2026-06-04 | Nagel Bradley M. | Option exercise | 5.3K | $10.71 |
| 2026-06-04 | Nagel Bradley M. | Sell | 12K | $36.34 |
| 2026-06-04 | Nagel Bradley M. | Sell | 181 | $37.11 |
| 2026-05-15 | SKARVAN KATHLEEN | Option exercise | 40K | $3.82 |
| 2026-05-15 | SKARVAN KATHLEEN | Sell | 8.2K | $34.36 |
| 2026-05-15 | SKARVAN KATHLEEN | Sell | 19K | $35.24 |
| 2026-05-15 | SKARVAN KATHLEEN | Sell | 9.3K | $36.26 |
| 2026-05-15 | SKARVAN KATHLEEN | Sell | 3.6K | $37.33 |
| 2025-12-01 | Tune Kathleen A | Grant | 3.0K | — |
| 2025-12-01 | Erickson Stan K. | Grant | 3.0K | — |
| 2025-12-01 | Fluet Gregory | Grant | 3.0K | — |
| 2025-12-01 | Galatowitsch Joseph L. | Grant | 3.0K | — |
| 2025-12-01 | SKARVAN KATHLEEN | Grant | 3.0K | — |
| 2025-12-01 | Walsh Andrea M. | Grant | 3.0K | — |
| 2025-12-01 | Summers Andrew | Grant | 3.0K | — |
| 2025-09-11 | Summers Andrew | Sell | 3.2K | $24.42 |
| 2025-09-10 | Summers Andrew | Sell | 404 | $26.62 |
| 2025-09-10 | Summers Andrew | Sell | 39K | $23.68 |
| 2025-09-10 | Summers Andrew | Sell | 16K | $25.16 |
| 2025-09-10 | Summers Andrew | Sell | 6.6K | $25.94 |
| 2025-09-02 | Cunniff James L. | Tax withheld | 1.3K | $23.95 |
| 2025-09-02 | Cunniff James L. | Grant | 17K | — |
| 2025-09-02 | Nagel Bradley M. | Tax withheld | 562 | $23.95 |
| 2025-09-02 | Nagel Bradley M. | Grant | 5.3K | — |
| 2025-02-24 | Summers Andrew | Sell | 51K | $27.30 |
| 2025-02-21 | Summers Andrew | Sell | 735 | $28.99 |
| 2025-02-21 | Summers Andrew | Sell | 12K | $28.16 |
| 2025-02-21 | Summers Andrew | Sell | 734 | $28.99 |
| 2025-02-21 | Summers Andrew | Sell | 12K | $28.16 |
| 2025-02-20 | Summers Andrew | Sell | 1.9K | $29.81 |
| 2025-02-20 | Summers Andrew | Sell | 16K | $28.71 |
| 2025-02-20 | Summers Andrew | Sell | 16K | $28.71 |
| 2025-02-20 | Summers Andrew | Sell | 1.9K | $29.81 |
| 2025-02-18 | SKARVAN KATHLEEN | Sell | 39K | $29.28 |
| 2025-02-18 | SKARVAN KATHLEEN | Sell | 5.0K | $29.15 |
| 2025-02-14 | SKARVAN KATHLEEN | Sell | 7.6K | $32.13 |
| 2025-02-14 | SKARVAN KATHLEEN | Option exercise | 40K | $1.80 |
| 2025-02-14 | SKARVAN KATHLEEN | Tax withheld | 15K | $33.21 |
| 2025-02-14 | SKARVAN KATHLEEN | Sell | 1.1K | $33.08 |
| 2025-02-14 | SKARVAN KATHLEEN | Sell | 24K | $32.07 |
| 2024-12-31 | Cunniff James L. | Option exercise | 88K | — |
| 2024-12-31 | Cunniff James L. | Tax withheld | 34K | $29.55 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT04271969 ↗ | Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population Bronchiectasis | — | Completed | 2023-12-01 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-12 | ResultsReg FDExhibits | filing ↗ |
| 2026-02-10 | ResultsReg FDExhibits | filing ↗ |
| 2025-12-18 | Material agreementDebt obligationExhibits | filing ↗ |
| 2025-11-18 | Shareholder vote | filing ↗ |
| 2025-11-12 | ResultsReg FDExhibits | filing ↗ |
| 2025-09-09 | Reg FDOtherExhibits | filing ↗ |
| 2025-08-26 | ResultsReg FDExhibits | filing ↗ |
| 2025-05-13 | ResultsReg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-12 | 2026-05-12 | 0001437749-26-016422 ↗ |
| 10-Q | 2026-05-12 | 2026-03-31 | 0001437749-26-016429 ↗ |
| 8-K | 2026-02-10 | 2026-02-10 | 0001437749-26-003636 ↗ |
| 10-Q | 2026-02-10 | 2025-12-31 | 0001437749-26-003635 ↗ |
| 8-K | 2025-12-18 | 2025-12-16 | 0001437749-25-038291 ↗ |
| 8-K | 2025-11-18 | 2025-11-14 | 0001437749-25-035598 ↗ |
| 8-K | 2025-11-12 | 2025-11-12 | 0001437749-25-034438 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001437749-25-034445 ↗ |
| 8-K | 2025-09-09 | 2025-09-09 | 0001437749-25-028605 ↗ |
| 8-K | 2025-08-26 | 2025-08-26 | 0001437749-25-027760 ↗ |
| 10-K | 2025-08-26 | 2025-06-30 | 0001437749-25-027761 ↗ |
| 10-Q | 2025-05-13 | 2025-03-31 | 0001437749-25-016450 ↗ |